These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 20209644

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Complete versus partial distal embolic protection during renal artery stenting.
    Kanjwal K, Haller S, Steffes M, Virmani R, Shapiro JI, Burket MW, Cooper CJ, Colyer WR.
    Catheter Cardiovasc Interv; 2009 May 01; 73(6):725-30. PubMed ID: 19198007
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Appropriate patient and device selection crucial for clinical benefit following renal stenting.
    Zeller T.
    Catheter Cardiovasc Interv; 2010 Jul 01; 76(1):24-5. PubMed ID: 20578189
    [No Abstract] [Full Text] [Related]

  • 5. Determinants of renal function in patients with renal artery stenosis.
    Yu H, Zhang D, Haller S, Kanjwal K, Colyer W, Brewster P, Steffes M, Shapiro JI, Cooper CJ.
    Vasc Med; 2011 Oct 01; 16(5):331-8. PubMed ID: 21908683
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Impact of thienopyridine administration prior to primary stenting in acute myocardial infarction.
    Rabbani LE, Iyengar S, Dangas GD, Grines CL, Cox DA, Garcia E, Tcheng JE, Griffin JJ, Guagliumi G, Stuckey T, Turco M, Stant J, Fahy M, Lansky AJ, Mehran R, Stone GW.
    J Interv Cardiol; 2009 Aug 01; 22(4):378-84. PubMed ID: 19496901
    [Abstract] [Full Text] [Related]

  • 13. Impact of abciximab on mortality and reinfarction in patients with acute ST-segment elevation myocardial infarction treated with primary stenting.
    Jeremias A, Vasu S, Gruberg L, Kastrati A, Stone GW, Brown DL.
    Catheter Cardiovasc Interv; 2010 May 01; 75(6):895-902. PubMed ID: 20088008
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Predictors of and outcomes of early thrombosis following balloon angioplasty versus primary stenting in acute myocardial infarction and usefulness of abciximab (the CADILLAC trial).
    Dangas G, Aymong ED, Mehran R, Tcheng JE, Grines CL, Cox DA, Garcia E, Griffin JJ, Guagliumi G, Stuckey T, Lansky AJ, Stone GW, CADILLAC Investigators.
    Am J Cardiol; 2004 Oct 15; 94(8):983-8. PubMed ID: 15476608
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Outcome in elderly patients undergoing primary coronary intervention for acute myocardial infarction: results from the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial.
    Guagliumi G, Stone GW, Cox DA, Stuckey T, Tcheng JE, Turco M, Musumeci G, Griffin JJ, Lansky AJ, Mehran R, Grines CL, Garcia E.
    Circulation; 2004 Sep 21; 110(12):1598-604. PubMed ID: 15353506
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.